Finance
Finance
StartsideABUS • NASDAQ
Tekmira Pharmaceuticals
4,12 $
21. jan., 13:39:12 GMT-5 · USD · NASDAQ · Ansvarsfraskrivelse
Forrige sluttkurs
4,21 $
Dagsintervall
4,12 $ - 4,33 $
Årsintervall
2,71 $ - 5,10 $
Markedsverdi
790,47 mill. USD
Gjennomsnittlig volum
1,55 mill.
P/E-tall
-
Utbytte
-
Hovedbørs
NASDAQ
Markedsnyheter
Nettavisen
for 6 timer siden
Advarer mot AI-boble: Kan utløse resesjon
NDAQ
1,69 %
NRK
for 1 døgn siden
Wall Street faller kraftig fra start
E24
for 1 døgn siden
Kraftig nedgang på Wall Street: – Dette er «selg Amerika»
Bitcoin.com News
for 11 timer siden
Canaan mottar Nasdaq-mangelvarsel etter at aksjene dupper under $1,00
NDAQ
1,69 %
BTC / USD
0,40 %
MarketBeat
for 19 minutter siden
Simmons First National (NASDAQ:SFNC) Trading 7.1% Higher After Strong Earnings
SFNC
6,90 %
CNBC
for 17 minutter siden
The S&P 500 and 10-year yield pain levels that could cause Trump to rethink Greenland push
.INX
0,39 %
Om
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Administrerende direktør
Grunnlagt
2007
Hovedkvarter
Warminster Township, Pennsylvania
USA
Nettsted
arbutusbio.com
Ansatte
44
Søk
Slett søket
Lukk søkefunksjonen
Google-apper
Hovedmeny